Use of model for end-stage liver disease exception points for early liver transplantation and successful reversal of hepatic myelopathy with a review of the literature

Liver Transplantation

Volumn 16, Issue 7, 2010, Pages 818-826

  Caldwell, Cary ^a   Werdiger, Norman ^a   Jakab, Sofia ^a   Schilsky, Michael ^a   Arvelakis, Antonios ^a   Kulkarni, Sanjay ^a   Emre, Sukru ^a  

^a YALE UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

MANGANESE; PEGINTERFERON; PREDNISONE; RIBAVIRIN; TACROLIMUS; VIRUS RNA;

ADULT; ANEMIA; ARTICLE; BLOOD LEVEL; CASE REPORT; DECOMPENSATED LIVER CIRRHOSIS; DISEASE COURSE; DRUG WITHDRAWAL; DYSESTHESIA; FOOT EDEMA; HEPATIC MYELOPATHY; HEPATITIS C VIRUS CIRRHOSIS; HISTOPATHOLOGY; HUMAN; HYPERREFLEXIA; LIVER BIOPSY; LIVER CIRRHOSIS; LIVER TRANSPLANTATION; LUMBAR PUNCTURE; MALE; MEDICAL LITERATURE; MOBILIZATION; MODEL; MODEL FOR END STAGE LIVER DISEASE; NUCLEAR MAGNETIC RESONANCE IMAGING; PARESTHESIA; PATELLA TENDON; PHYSIOTHERAPY; PRIORITY JOURNAL; PYRAMIDAL TRACT; SPASTIC PARAPLEGIA; SPINAL CORD DISEASE; TENDON REFLEX; THROMBOCYTOPENIA; WEAKNESS; WHEELCHAIR; DECISION SUPPORT SYSTEM; LIVER DISEASE; MIDDLE AGED; REVIEW; TIME; TRANSPLANTATION; TREATMENT OUTCOME;

DECISION SUPPORT TECHNIQUES; HUMANS; LIVER DISEASES; LIVER TRANSPLANTATION; MALE; MIDDLE AGED; SPINAL CORD DISEASES; TIME FACTORS; TISSUE AND ORGAN PROCUREMENT; TREATMENT OUTCOME;

EID: 77954169727     PISSN: 15276465     EISSN: 15276473     Source Type: Journal    
DOI: 10.1002/lt.22077     Document Type: Article

References (40)

1. Zieve L, Mendelson DF, Goepfert M. Shunt encephalomyelopathy. II. Occurrence of permanent myelopathy. Ann Intern Med 1960;53:53-63.
2. Drake A, Patterson M. Chronic permanent encephalomyelopathy following hepatic shunts. South Med J 1964; 57:617-621.
3. Skobie BA, Summerskill WHJ. Permanent paraplegia with cirrhosis. Arch Intern Med 1964;113:805-810.
4. Liversedge LA, Rawson MD. Myelopathy in hepatic disease and portosystemic venous anastamosis. Lancet 1966;1:277-279.
5. Pant SS, Rebeiz JJ, Richardson EP Jr. Spastic paraparesis following portocaval shunts. Neurology 1968;18: 135-141.
6. Mousseau R, Reynolds T. Hepatic paraplegia. Am J Gastroenterol 1976;66:343-348.
7. Bechar M, Freud M, Kott E, Kott H, Kravic H, Stern J, et al. Hepatic cirrhosis with postshunt myelopathy. J Neurol Sci 1979;11:101-107.
8. Bain VG, Bailey RJ, Jhamandas JH. Postshunt myelopathy. J Clin Gastroenterol 1991;13:562-564.
9. Demirci M, Tan E, Elibol B, Gedikoglu G, Saribas O. Spastic paraparesis associated with portal-systemic venous shunting due to congenital hepatic fibrosis. Neurology 1992;42:983-985.
10. Mendoza G, Marti-Fabregas J, Kulisevsky J, Escartin A. Hepatic myelopathy: a rare complication of portacaval shunt. Eur Neurol 1994;34:209-212. (Pubitemid 24158566)
11. Sobukawa E, Sakimura K, Hoshino S, Hoshino M, Miyoshi K. Hepatic myelopathy: an unusual neurological complication of advanced hepatic disease. Intern Med 1994;33:718-722.
12. Campellone JV, Lacomis D, Giuliani MJ, Kroboth FJ. Hepatic myelopathy. Case report with review of the literature. Clin Neurol Neurosurg 1996;98:242-246.
13. Conn HO, Rossle M, Levy L, Glocker FX. Portosystemic myelopathy: spastic paraparesis after portosystemic shunting. Scand J Gastroenterol 2006;41:619-625.
14. Gospe SM, Caruso RD, Clegg MS, Keen CL, Pimstone NR, Ducore JM, et al. Paraparesis, hypermanganesaemia, and polycytheaemia: a novel presentation of cirrhosis. Arch Dis Child 2000;83:439-442.
15. Utku U, Asil T, Balci K, Uzunca I, Celik Y. Hepatic myelopathy with spastic paraparesis. Clin Neurol Neurosurg 2005;107:514-516.
16. Panicker J, Sinha S, Taly AB, Ravishankar S, Arunodaya GR. Hepatic myelopathy: a rare complication following extrahepatic portal vein occlusion. Neurol India 2006;54: 298-300. (Pubitemid 44341771)
17. Counsell C, Warlow C. Failure of presumed hepatic myelopathy to improve after liver transplantation. J Neurol Neurosurg Psychiatry 1996;60:590. (Pubitemid 26147910)
18. Troisi R, Debruyne J, de Hemptinne B. Improvement of hepatic myelopathy after liver transplantation. N Engl J Med 1999;340:151.
19. Weissenborn K, Tietge UJ, Bokemeyer M, Mohammadi B, Bode U, Manns MP, Caselitz M. Liver transplantation improves hepatic myelopathy: evidence by three cases. Gastroenterology 2003;124:346-351.
20. Nardone R, Buratti T, Oliviero A, Lochmann A, Tezzon F. Corticospinal involvement in patients with a portosystemic shunt due to liver cirrhosis: a MEP study. J Neurol 2006;253:81-85.
21. Koo JE, Lim YS, Myung SJ, Suh KS, Kim KM, Lee HC, et al. Hepatic myelopathy as a presenting neurological complication in patients with cirrhosis and spontaneous splenorenal shunt. Korean J Hepatol 2008;14: 89-96.
22. Qu B, Liu C, Guo L, Yang Y, Li JH, Yu L, Lv Y. The role of liver transplantation of hepatic myelopathy: case report with review of the literature. Transplant Proc 2009;41:1987-1909.
23. Pinarbasi B, Kaymakoglu S, Matur Z, Akyuz F, Demir K, Besisik F, et al. Are acquired hepatocerebral degeneration and hepatic myelopathy reversible? J Clin Gastroenterol 2009;43:176-181.
24. Lewis M, Howdle PD. The neurology of liver failure. Q J Med 2003;96:623-633.
25. Sherlock S, Summerskill WHJ, White LP, Phear EA. Portal-systemic encephalopathy: neurological complications of liver disease. Lancet 1954;4:453-457.
26. Zieve L, Mendelson DF, Goepfert M. Shunt encephalopathy. I. Recurrent protein encephalopathy with response to arginine. Ann Intern Med 1960;53:33-52.
27. Stables DP, Levin B, Elliott GA, DuPlessis DL. Colonic exclusion for chronic portal-systemic encephalomyelopathy. Ann Intern Med 1966;65:326-329.
28. Nolano M, Guardascione MA, Amitrano L, Perretti A, Fiorillo F, Ascione A, et al. Corticospinal pathways and inhibitory mechanisms in hepatic encephalopathy. Electroencephalogr Clin Neurophysiol 1997;105:72-78.
29. Leigh AD, Card WI. Hepato-lenticular degeneration. A case associated with posterior-lateral column degeneration. J Neuropathol Exp Neurol 1949;8:338
30. Rovira A, Cordoba J, Sanpedro E, Grive E, Rovira-Gols A, Alonso J. Normalization of T2 signal abnormalities in hemispheric white matter with liver transplant. Neurology 2002;59:335-341. (Pubitemid 34857924)
31. Kulisevsky J, Pujol J, Balanzo J, Jungque C, Deus J, Capdevilla A, Villanueva C. Pallidal hyperintensity on magnetic resonance imaging in cirrhotic patients: clinical correlations. Hepatology 1992;16:1382-1388.
32. Skehan S, Norris S, Hegarty J, Owens A, MacErlaine D. Brain MRI changes in chronic liver disease. Eur Radiol 1997;7:905-909. (Pubitemid 127537110)
33. Santos-Garcia D, Aria-Rivas S, Dapena D, Arias M. Past hepatitis B infection and demyelinating multiphasic disease: casual or causal relationship? Neurologia 2007;22: 542-546.
34. Khemiri M, Ouederni M, Barsaoui S. A new case of acute transverse myelitis following hepatitis A infection. Med Mal Infect 2007;37:237-239.
35. Misumi H, Ishibashi H, Kanayama K, Kajiyama W, Nomura H, Sugimoto T, et al. Necrotizing myelopathy associated with hepatocellular carcinoma. Jpn J Med 1988;27:333-336.
36. Lefer LG, Vogel FS. Encephalomyelopathy with hepatic cirrhosis following portosystemic venous shunts. Arch Pathol 1972;93:91-97.
37. Budillon G, Scala G, Mansi D, Campanella G. Hepatic paraplegia: an uncommon complication of portosystemic shunt. Acta Neurol 1979;1:93-100. (Pubitemid 9222435)
38. Read AE, Sherlock S, Laidlaw J, Walker JG. The neuro-psychiatric syndromes associated with chronic liver disease and an extensive portal-systemic collateral circulation. Q J Med 1967;36:135-150.
39. Miller AE. Overview to approach to the patient with non-compressive myelopathy. Continuum 2005;11:13-24.
40. Wong SH, Boggild M, Enevoldson TP, Fletcher N. Myelopathy but normal MRI: where next? Pract Neurol 2008;8: 90-102.